Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Feiyun Chang, Jiali Li, Quan Sun, Shuqing Wei & Yongming Song. (2022) Hsa_circ_0017639 regulates cisplatin resistance and tumor growth via acting as a miR-1296-5p molecular sponge and modulating sine oculis homeobox 1 expression in non-small cell lung cancer. Bioengineered 13:4, pages 8806-8822.
Read now
Read now
Hailing Zhu, Quan Lu, Qing Lu, Xuemin Shen & Liuyang Yu. (2021) RETRACTED ARTICLE: Matrine Regulates Proliferation, Apoptosis, Cell Cycle, Migration, and Invasion of Non-Small Cell Lung Cancer Cells Through the circFUT8/miR-944/YES1 Axis. Cancer Management and Research 13, pages 3429-3442.
Read now
Read now
Xu Danni, Zeng Jiangzheng, Sun Huamao, Pan Yinglian, Yang Changcheng & Lu Yanda. (2021) Chaperonin containing TCP1 subunit 3 (CCT3) promotes cisplatin resistance of lung adenocarcinoma cells through targeting the Janus kinase 2/signal transducers and activators of transcription 3 (JAK2/STAT3) pathway. Bioengineered 12:1, pages 7335-7347.
Read now
Read now
Junbin Wang, Jin Gao, Qinnan Chen, Weiyan Zou, Fen Yang, Chenchen Wei & Zhaoxia Wang. (2020) RETRACTED ARTICLE: LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma. OncoTargets and Therapy 13, pages 9333-9348.
Read now
Read now
Yuan Hong, Shaomin Che, Beina Hui, Xiaoli Wang, Xiaozhi Zhang & Hailin Ma. (2020) Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine. Drug Design, Development and Therapy 14, pages 2263-2274.
Read now
Read now
Li Zhang, Hao Bo, Tingwei Chen, Qiaohua Li, Ye Huan & Shanshan Zhang. (2020)
FOXD2-AS1 promotes migration and invasion of head and neck squamous cell carcinoma and predicts poor prognosis. Future Oncology 16:28, pages 2209-2218.
Read now
Read now
Articles from other publishers (27)
Soudeh Ghafouri-Fard, Atefeh Harsij, Bashdar Mahmud Hussen, Hasan Pourmoshtagh & Mohammad Taheri. (2024) A review on the role of FOXD2-AS1 in human disorders. Pathology - Research and Practice 254, pages 155101.
Crossref
Crossref
Meibin Wang, Yujie Fu, Chuyue Zhong, Rajesh N. Gacche & Peiliang Wu. (2023) Long non-coding RNA and Evolving drug resistance in lung cancer. Heliyon 9:12, pages e22591.
Crossref
Crossref
Esmat Abdi, Saeid Latifi-Navid, Alireza Panahi & Hamid Latifi-Navid. (2023) LncRNA polymorphisms and lung cancer risk. Personalized Medicine.
Crossref
Crossref
Wenjuan Liu, Bingli Zuo, Wenting Liu, Yanfei Huo, Nasha Zhang & Ming Yang. (2023) Long non-coding RNAs in non-small cell lung cancer: implications for preventing therapeutic resistance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:6, pages 188982.
Crossref
Crossref
Eleonora A. Braga, Marina V. Fridman, Alexey M. Burdennyy, Vitaly I. Loginov, Alexey A. Dmitriev, Irina V. Pronina & Sergey G. Morozov. (2023) Various LncRNA Mechanisms in Gene Regulation Involving miRNAs or RNA-Binding Proteins in Non-Small-Cell Lung Cancer: Main Signaling Pathways and Networks. International Journal of Molecular Sciences 24:17, pages 13617.
Crossref
Crossref
Hooman Shalmashi, Sahar Safaei, Dariush Shanehbandi, Milad Asadi, Soghra Bornehdeli & Abdolreza Mehdi Navaz. (2022) Evaluation of lncRNA FOXD2-AS1 Expression as a Diagnostic Biomarker in Colorectal Cancer. Reports of Biochemistry and Molecular Biology 11:3, pages 471-478.
Crossref
Crossref
Soudeh Ghafouri-Fard, Sepideh Dashti, Leila Gholami, Elham Badrlou, Saba Sadeghpour, Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Naghme Nazer, Mahdi Shadnoush, Arezou Sayad & Noormohammad Arefian. (2022) Expression analysis of Wnt signaling pathway related lncRNAs in periodontitis: A pilot case-control study. Human Gene 33, pages 201069.
Crossref
Crossref
Zhihai Li, Qiaozhi Jin & Yana Sun. (2022) LINC00941 promoted in vitro progression and glycolysis of laryngocarcinoma by upregulating PKM via activating the PI3K/AKT/mTOR signaling pathway. Journal of Clinical Laboratory Analysis 36:7.
Crossref
Crossref
Wenyu Chen, Xiaoli Tan, Qi Yang, Zhixian Fang & Yufen Xu. (2022) MALAT1 enhances gemcitabine resistance in non-small cell lung cancer cells by directly affecting miR-27a-5p/PBOV1 axis. Cellular Signalling 94, pages 110326.
Crossref
Crossref
Qiang Shen, Huixin Zhou, Meijuan Zhang, Ruihao Wu, Liangxing Wang, Yumin Wang & Jie Chen. (2022) Super enhancer‐LncRNA SENCR promoted cisplatin resistance and growth of NSCLC through upregulating FLI1. Journal of Clinical Laboratory Analysis 36:6.
Crossref
Crossref
Yi Li, Xiaojuan Yang & Xue Xiong. (2022) Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer. Genomics 114:2, pages 110294.
Crossref
Crossref
Mohammad Taheri, Hamed Shoorei, Farhad Tondro Anamag, Soudeh Ghafouri-Fard & Marcel E. Dinger. (2021) LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin. Experimental and Molecular Pathology 123, pages 104602.
Crossref
Crossref
Qiaohong Nong, Shaokang Yu, Hui Hu & Xue Hu. (2021) Knockdown of lncRNA FOXD2-AS1 Inhibits Proliferation, Migration, and Drug Resistance of Breast Cancer Cells. Computational and Mathematical Methods in Medicine 2021, pages 1-9.
Crossref
Crossref
Jinjun Ye, Jidong Liu, Tao Tang, Le Xin, Xing Bao & Yukuang Yan. (2021) miR‑4306 inhibits the malignant behaviors of colorectal cancer by regulating lncRNA FoxD2‑AS1. Molecular Medicine Reports 24:4.
Crossref
Crossref
Jiaying He, Shaomi Zhu, Xin Liang, Qinxiu Zhang, Xiaohong Luo, Chi Liu & Linjiang Song. (2021) LncRNA as a multifunctional regulator in cancer multi-drug resistance. Molecular Biology Reports 48:8, pages 1-15.
Crossref
Crossref
Ting Han, Mingbo Gao, Xin Wang, Wei Li, Jialu Zhuo, Zhihua Qu & Yiqiu Chen. (2021) LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1. Experimental and Molecular Pathology 120, pages 104639.
Crossref
Crossref
Wei Wang, Pengfei Wang, Kaihui Xie, Ruirui Luo, Xiaoli Gao, Zunqiang Yan, Xiaoyu Huang, Qiaoli Yang & Shuangbao Gun. (2021) ssc-miR-185 targets cell division cycle 42 and promotes the proliferation of intestinal porcine epithelial cell. Animal Bioscience 34:5, pages 801-810.
Crossref
Crossref
Hua-Si Zhao, Xiao-Min Tao, Qun Wang, Yuan-Yuan Fang, Hong-Yu Zhang, Hua-Qi Wang & Guo-Jun Zhang. (2021) Silencing SIX1 by miR-7160 inhibits non-small cell lung cancer cell growth. Aging 13:6, pages 8055-8067.
Crossref
Crossref
Wenhua Xue, Zhibo Shen, Lifeng Li, Yuanyuan Zheng, Dan Yan, Quancheng Kan & Jie Zhao. (2021) Long non-coding RNAs MACC1-AS1 and FOXD2-AS1 mediate NSD2-induced cisplatin resistance in esophageal squamous cell carcinoma. Molecular Therapy - Nucleic Acids 23, pages 592-602.
Crossref
Crossref
Dajin Chen, Shangzhi Xie, Ying Wu, Yu Cui, Ying Cai, Lan Lan, Hao Yang, Jianghua Chen & Wei Chen. (2021) Reduction of Bladder Cancer Chemosensitivity Induced by the Effect of HOXA-AS3 as a ceRNA for miR-455-5p That Upregulates Notch1. Frontiers in Oncology 10.
Crossref
Crossref
Yanchi Yuan, Erjing Li, Jing Zhao, Bolin Wu, Ziyue Na, Wen Cheng & Hui Jing. (2020) Highly penetrating nanobubble polymer enhances LINC00511-siRNA delivery for improving the chemosensitivity of triple-negative breast cancer. Anti-Cancer Drugs 32:2, pages 178-188.
Crossref
Crossref
Xuhui Yang, Lifei Meng, Yuang Zhong, Fengqing Hu, Lei Wang & Mingsong Wang. (2021) The long intergenic noncoding RNA GAS5 reduces cisplatin-resistance in non-small cell lung cancer through the miR-217/LHPP axis. Aging 13:2, pages 2864-2884.
Crossref
Crossref
Zheqi Liu, Wenkai Zhou, Chengzhong Lin, Xiaoning Wang, Xu Zhang, Yu Zhang, Rong Yang, Wantao Chen & Wei Cao. (2020) Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data. Aging 13:2, pages 2379-2396.
Crossref
Crossref
Shuyao Zhang, Wei Liao, Qinshui Wu, Xiaoshan Huang, Zhen Pan, Wang Chen, Shuyi Gu, Zuojun Huang, Yiwen Wang, Xu Tang, Shanshan Liang, Xiaoyan Zhang, Yun Chen, Shuang Chen, Wanying Chen, Yi Jiang, Chen Chen & Guodong Qiu. (2020) LINC00152 upregulates ZEB1 expression and enhances epithelial-mesenchymal transition and oxaliplatin resistance in esophageal cancer by interacting with EZH2. Cancer Cell International 20:1.
Crossref
Crossref
Tiancheng Zhao, Jiayu Zhang, Cong Ye, Leilei Tian & Yezhou Li. (2020) lncRNA FOXD2-AS1 promotes hemangioma progression through the miR-324-3p/PDRG1 pathway. Cancer Cell International 20:1.
Crossref
Crossref
Yongping Zhang, Chaojie Liang, Yu Zhang, Zhinmin Wang, Ruihuan Li, Zhigang Wei & Jiansheng Guo. (2020) The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles. Bioscience Reports 40:11.
Crossref
Crossref
Qiming Shen, Zhe Xu & Shun Xu. (2020) Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer. International Journal of Oncology.
Crossref
Crossref